Dr. Robert I. Lynn, MD

Dr. Lynn practices at DaVita Bronx Dialysis Center in Bronx, New York.

Dr. Lynn's NPI, 1851388862, was assigned on October 4, 2005. Dr. Lynn graduated from Columbia University College of Physicians and Surgeons in 1974. Dr. Lynn holds New York license 125759.

Dr. Lynn's primary practice is DaVita Bronx Dialysis Center, at 1615 Eastchester Road, Bronx, NY 10461 in Bronx County. The practice phone is (718) 892-7700.

Dr. Lynn's primary practice is DaVita Bronx Dialysis Center in Bronx, New York. Dr. Lynn is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Kidney Medical Associates. Dmand AI also links Dr. Lynn to 1 more dialysis center, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lynn practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lynn's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lynn is licensed in New York.

CMS data shows 1,294 Medicare services from Dr. Lynn across 12 procedure codes in 2024, for 115 Medicare patients. Medicare paid $99,724 for them. Every service was in an office.

CMS counts 115 Medicare patients who saw Dr. Lynn in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 37% are also on Medicaid. Their average risk score is 3.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lynn's median patient age at 66, with 48% women.

In 2024, Dr. Lynn wrote 2,787 Medicare Part D claims for 209 patients. 74% of them were for generic drugs. CMS names the drug for 2,261 of them, across 69 drugs with 11 or more claims each, at $861,122 in total drug cost. In 2023, CMS named 2,135 claims across 65 drugs.

Dr. Lynn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lynn as offering telehealth.

Dmand AI links 4 papers to Dr. Lynn, published from 2020 to 2024. The most frequent topics are Renal Dialysis, Isoquinolines and Sulfonamides. Dr. Lynn has published most often in Kidney360. Dr. Lynn's most frequent co-authors are Arnold Silva, MD, PhD, Geoffrey Allan Block, MD and Glenn Matthew Chertow, MD.

Dmand AI links Dr. Lynn to 3 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Renal Insufficiency, Chronic, Kidney Failure, Chronic and Obesity. GlaxoSmithKline sponsors the most, 2. Open Payments lists research payments to Dr. Lynn that name 1 trial.

CMS Open Payments shows 299 general payments to Dr. Lynn from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. Fresenius USA Marketing, Inc. paid the most, $15,707. It also lists 1 research payment totaling $275 in 2023, naming 1 clinical trial.

Dr. Lynn graduated from Columbia University College of Physicians and Surgeons in 1974.